Michael Scolaro

Michael Scolaro

Oct 16, 2017

Group 6 Copy 31
-1
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Developing a novel oxysterol antibiotic to combat drug-resistant tuberculosis

    Drug-resistant tuberculosis (TB) is a consistently growing threat to global health. We have developed Oxy291...

    Part 2: Can low carbohydrate ketogenic diets inhibit cancers?

    We've identified that ketone bodies, i.e. fuels in the bloodstream that result from a very low carbohydrate...

    Making Inexpensive Insulin Using Microalgae

    This page serves as an archive of our first proof-of-concept experiments to genetically modify microalgae...

    Backer Badge Funded